Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TLV/PLUR stock hub

TLV/PLUR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TLV/PLURis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
101.5M
Tel Aviv Stock Exchange
Market data

Price

Recent price action with selectable time range.

TLV/PLURTLV/PLUR
Loading chart…
In the news

Latest news · TLV/PLUR

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC-59.7
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TLV/PLUR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
174
Groups with data
11
Currency
USD
Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United States
Country code
IL
Employees
135
Employees Change
24%
Employees Change Percent
20.34
Enterprise value
ILA 182.3M
Exchange
Tel Aviv Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biotechnology
Isin
US72942G2030
Last refreshed
2026-05-10
Market cap
ILA 101.5M
Price
ILA 1,012
Price currency
ILA
Rev Per Employee
31,620.24x
Sector
Healthcare
Sic
2836
Symbol
tlv/PLUR
Website
https://www.pluri-biotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-82.06%
EV Earnings
-2.19x
EV/FCF
-2.6x
EV/Sales
46.96x
FCF yield
-69.11%
P/B ratio
-3.46x
P/S ratio
23.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
Gross margin
40.63%
Gross Profit
ILA 1.7M
Gross Profit Growth
14.77%
Gross Profit Growth Q
-22.52%
Gross Profit Growth3 Y
18.98%
Gross Profit Growth5 Y
252.47%
Net Income
ILA -83.3M
Net Income Growth Years
0%
Pretax Margin
-2,026.06%
Profit Per Employee
ILA -617,244
ROA
-50.6
Roa5y
-33.34
ROCE
1,421.5
Roe5y
-306.1
ROIC
-59.68

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr10y
-32.19%
Cagr15y
-24.94%
Cagr1y
-41.73%
Cagr3y
-28.43%
Cagr5y
-36.91%
EPS Growth Years
4
Revenue Growth
97.49x
Revenue Growth Q
7.03x
Revenue Growth Quarters
1x
Revenue Growth Years
3x
Revenue Growth3 Y
60.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Asset Turnover
ILA 0.04
Assets
ILA 97.5M
Cash
ILA 39.8M
Current Assets
ILA 40M
Current Liabilities
ILA 93.8M
Debt
ILA 111.4M
Debt FCF
ILA -1.59
Equity
ILA -29.4M
Interest Coverage
-27.49
Liabilities
ILA 126.9M
Long Term Assets
ILA 57.5M
Long Term Liabilities
ILA 33.1M
Net Cash
ILA -71.6M
Net Cash By Market Cap
ILA -70.5
Tangible Book Value
ILA -65.2M
Tangible Book Value Per Share
ILA -6.53

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
0.43
Net Working Capital
ILA -8.1M
Quick ratio
0.39
Working Capital
ILA -59.1M
Working Capital Turnover
ILA -13.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-50.78%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
-97.94%
1Y total return
-41.71%
200-day SMA
1,278
3Y total return
-63.34%
50-day SMA
1,057.5
50-day SMA vs 200-day SMA
50under200
5Y total return
-90%
All Time High
158,960
All Time High Change
-99.36%
All Time High Date
2012-09-11
All Time Low
922.9
All Time Low Change
9.65%
All Time Low Date
2026-01-07
ATR
47.19
Ch YTD
5.14
High
1,050
High52
2,066
High52 Date
2025-05-12
High52ch
-51.02%
Low
977.7
Low52
922.9
Low52 Date
2026-01-07
Low52ch
9.65%
Ma50ch
-4.3%
Price vs 200-day SMA
-20.81%
RSI
45.57
RSI Monthly
33.39
RSI Weekly
56.17
Sharpe ratio
-0.44x
Sortino ratio
-0.61
Total Return
-50.78%
Tr YTD
5.14
Tr15y
-98.65%
Tr1m
-5.95%
Tr1w
-0.98%
Tr3m
-13.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
ILA -79.3M
Operating margin
-1,857.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
3,902,458%
Shares Insiders
40.81%
Shares Institutions
13.48%
Shares Qo Q
2.94%
Shares Yo Y
50.78%
Short Ratio
3.79

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
ILA -81.2M
Average Volume
3,992.75x
Bv Per Share
-4.67
CAPEX
ILA -5.9M
Ch10y
-97.94
Ch15y
-98.65
Ch1m
-5.95
Ch1w
-0.98
Ch1y
-41.71
Ch3m
-13.65
Ch3y
-63.34
Ch5y
-90
Ch6m
-6.3
Change
2.09%
Change From Open
2.09
Close
991.3
Days Gap
0
Depreciation Amortization
1,282,242
Dollar Volume
1,487,640
Earnings Date
2026-05-15
EBIT
ILA -79.3M
EBITDA
ILA -77.9M
EPS
ILA -10.23
F Score
3
FCF
ILA -70.2M
FCF EV Yield
-38.5x
Financing CF
39,454,688
Fiscal Year End
June
Founded
2,001
Goodwill
9,097,536
Income Tax
ILA -66,948
Investing CF
16,909,152
Is Primary Listing
0
Last Earnings Date
2026-02-06
Last Report Date
2025-12-31
Last Split Date
2024-04-01
Last Split Type
Reverse
Ma150
1,131
Ma150ch
-10.52%
Ma20
1,036.2
Ma20ch
-2.34%
Net CF
-7,769,156
Next Earnings Date
2026-05-15
Open
991.3
Position In Range
47.44
Ppne
26,436,813
Price Date
2026-05-08
Relative Volume
0.37x
Revenue
4,268,732x
SBC By Revenue
257.06x
Share Based Comp
10,973,096
Tax By Revenue
-1.57x
Tr6m
-6.3%
Volume
1,470
Z Score
-23.69
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TLV/PLUR pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/PLUR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-41.7%
S&P 500 1Y: n/a
3Y total return
-63.3%
S&P 500 3Y: n/a
5Y total return
-90.0%
S&P 500 5Y: n/a
10Y total return
-97.9%
S&P 500 10Y: n/a
Ownership

Who owns TLV/PLUR?

Insider, institutional, and short-interest positioning.

Institutional ownership
+13.5%
Share of float held by funds and institutions
Insider ownership
+40.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
3.8 days to cover
Y/Y dilution
+50.8%
Negative means the company is buying back shares.
Technical

TLV/PLUR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
45.6
Neutral momentum band
Price vs 200-day MA
-20.8%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.44
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TLV/PLUR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/PLUR stock rating?

tlv/PLUR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/PLUR analysis?

The full report lives at /stocks/tlv/PLUR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/PLUR?

The latest report frames tlv/PLUR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/PLUR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.